Genetic and non‐genetic drug resistance: Darwin or Lamarck?

Abstract excerpt

Drug resistance represents a major limitation to the long-term efficacy of anti-cancer treatments. The commonly accepted view is that the selection of inheritable genetic mechanisms governs the development of secondary resistance. However, compelling evidence suggests an important role for adaptive cell plasticity and non-genetic mechanisms in the development of therapy resistance. The two phenomena are not...

Topics

Join the communities discussing this publication.

• Lung Cancer Treatments and Mutations
• Cancer Genomics and Diagnostics
• Evolution and Genetic Dynamics